Daiken Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	3,663	1,140	287.07	243.71
Cash & Short-Term Investments	5,063	1,140	287.07	243.71
Cash Growth	297.85%	297.03%	17.79%	-
Accounts Receivable	105.79	93.5	68.19	53.54
Other Receivables	0.11	0.65	3.33	-
Receivables	105.9	94.15	71.51	53.54
Inventory	400.53	245.71	262.65	178.36
Prepaid Expenses	36.33	31.89	19.39	17.58
Other Current Assets	-	-	92.12	30.71
Total Current Assets	5,605	1,511	732.73	523.9
Property, Plant & Equipment	20.22	3.28	-	-
Other Intangible Assets	4.82	3.74	1.46	1.09
Long-Term Deferred Tax Assets	9.57	11.69	6.53	-
Other Long-Term Assets	13.23	7.62	4.45	5.18
Total Assets	5,653	1,538	745.17	530.17
Accounts Payable	145.59	73.75	53.15	32.4
Accrued Expenses	64.4	63.24	89.3	87.6
Short-Term Debt	-	-	158	33
Current Portion of Long-Term Debt	-	-	69.02	41.63
Current Portion of Leases	3.17	1.82	-	-
Current Income Taxes Payable	32.83	9.37	28.15	19.36
Current Unearned Revenue	7.96	7.26	30.23	21.46
Other Current Liabilities	34.6	74.93	20.45	5.91
Total Current Liabilities	288.55	230.37	448.29	241.37
Long-Term Debt	-	-	49.56	61.37
Long-Term Leases	15.99	0.45	-	-
Total Liabilities	304.81	230.81	497.85	302.74
Common Stock	810.02	600.02	155.4	155.4
Additional Paid-In Capital	4,415	624.06	-	-
Retained Earnings	117.7	83.76	91.92	72.03
Comprehensive Income & Other	6.2	-0.86	-	-
Shareholders' Equity	5,349	1,307	247.32	227.43
Total Liabilities & Equity	5,653	1,538	745.17	530.17
Total Debt	19.16	2.27	276.58	136
Net Cash (Debt)	5,044	1,137	10.49	107.71
Net Cash Growth	411.42%	10746.37%	-90.26%	-
Net Cash Per Share	82.04	25.90	0.47	6.91
Filing Date Shares Outstanding	81	60	15.54	15.54
Total Common Shares Outstanding	81	60	15.54	15.54
Working Capital	5,317	1,281	284.44	282.53
Book Value Per Share	66.03	21.78	15.92	14.64
Tangible Book Value	5,344	1,303	245.86	226.34
Tangible Book Value Per Share	65.97	21.72	15.82	14.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.